Funding Rounds
LimmaTech Biologics Series A (2024, $3M)
LimmaTech BiologicsSelf-adjuvanting and multi-antigen vaccine technology platform.
Summary
Stage: Series A
Raised Amount: $3.00M
Raised Date: 2024-01-01
Stage: Series A
Raised Amount: $3.00M
Raised Date: 2024-01-01
